JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C4283 BW 246C

Summary: DP receptor agonist

≤50 mg/mL
C5136 Oxy-16

Summary: antagonist of hedgehog activity

≤10 mg/mL
C5709 AGK7

Summary: cell-permeable, selective inhibitor of SIRT2

≤0.5 mg/mL
B5571 MNI 137

Summary: negative allosteric modulator of group II mGlu receptors

<17.06 mg/mL
B5596 ISX 9

Summary: neurogenic agent

≥23.4 mg/mL
B5612 BAY 60-6583

Target: Adenosine A2B Receptors

Summary: Potent A2B receptor agonist

≥36.1 mg/mL
B8016 UNC2025
1 Citation

Target: MER|FLT3

Summary: orally bioavailable dual MER/FLT3 inhibitor

≥23.85 mg/mL
B7785 LDN 209929 dihydrochloride

Target: haspin kinase

Summary: haspin kinase inhibitor

<40.58 mg/mL
B4797 HSP990 (NVP-HSP990)

Target: HSP90

Summary: Hsp90 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥12.3 mg/mL
B4882 PF-06463922

Target: ALK|ROS1

Summary: ALK/ROS1 inhibitor,potent and selective

insoluble in H2O; ≥20.3 mg/mL